<abstract xmlns="http://www.w3.org/1999/xhtml">

<p>This article is aimed to provide an overview of psoriasis clinical aspects, available treatment options for moderate-to-severe psoriasis in Baltics and summarises recommendations of authors for use of different biologicals in psoriasis patients under a limited reimbursement environment.</p>
</abstract>

This article is aimed to provide an overview of psoriasis clinical aspects, available treatment options for moderate-to-severe psoriasis in Baltics and summarises recommendations of authors for use of different biologicals in psoriasis patients under a limited reimbursement environment.

Immunopathogenic Treatment Options for Psoriasis Patients Under a Restrictive Reimbursement Environment

Proceedings of the Latvian Academy of Sciences. Section B. Natural, Exact, and Applied Sciences.

This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

This article is aimed to provide an overview of psoriasis clinical aspects, available treatment options for moderate-to-severe psoriasis in Baltics and...

Immunopathogenic Treatment Options for Psoriasis Patients Under a Restrictive Reimbursement Environment

Publicado en línea: 22 jul 2021

Páginas: 158 - 166

Recibido: 11 jun 2020

Aceptado: 01 mar 2021

DOI: https://doi.org/10.2478/prolas-2021-0025

Palabras clave
autoimmune skin disorder, biological therapy, state compensation, Baltic

© 2020 Ilona Hartmane et al., published by Sciendo

This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

Immunopathogenic Treatment Options for Psoriasis Patients Under a Restrictive Reimbursement Environment

Publicado en línea: 22 jul 2021

Páginas: 158 - 166

Recibido: 11 jun 2020

Aceptado: 01 mar 2021

DOI: https://doi.org/10.2478/prolas-2021-0025

Palabras claveautoimmune skin disorder, biological therapy, state compensation, Baltic

© 2020 Ilona Hartmane et al., published by Sciendo

This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

Palabras clave
autoimmune skin disorder, biological therapy, state compensation, Baltic